Covaxin overall efficacy at 77.8%, says Bharat Biotech

Indigenously developed Covaxin has an overall efficacy of 77.8% against symptomatic Covid-19 and is 65.2% effective against the deadly Delta (B.1.617.2) variant that was first detected in India, its developer Bharat Biotech said on Saturday.

Admin Admin
Jul 4, 2021 - 10:07
0 7
Covaxin overall efficacy at 77.8%, says Bharat Biotech
Linkup
Indigenously developed Covaxin has an overall efficacy of 77.8% against symptomatic Covid-19 and is 65.2% effective against the deadly Delta (B.1.617.2) variant that was first detected in India, its developer Bharat Biotech said on Saturday.
Read More